FAM82A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.168400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.590400E-01
Normal-vs-Stage2
3.403800E-01
Normal-vs-Stage3
7.603200E-01
Normal-vs-Stage4
5.344600E-01
Stage1-vs-Stage2
1.988630E-01
Stage1-vs-Stage3
6.713000E-01
Stage1-vs-Stage4
5.410600E-01
Stage2-vs-Stage3
1.401370E-01
Stage2-vs-Stage4
5.814800E-01
Stage3-vs-Stage4
4.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.374800E-01
Normal-vs-AfricanAmerican
4.710000E-01
Normal-vs-Asian
3.580200E-01
Caucasian-vs-AfricanAmerican
8.191200E-01
Caucasian-vs-Asian
5.000800E-01
AfricanAmerican-vs-Asian
5.627200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.609200E-01
Normal-vs-Female
3.757400E-01
Male-vs-Female
7.260600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.482600E-01
Normal-vs-Age(41-60Yrs)
2.104200E-01
Normal-vs-Age(61-80Yrs)
5.361200E-01
Normal-vs-Age(81-100Yrs)
5.687600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.280600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.557600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.187000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.270300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.036200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.988200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.121400E-01
Normal-vs-Daily Drinker
3.665400E-01
Normal-vs-Weekly Drinker
3.766600E-01
Normal-vs-Occasional Drinker
5.060600E-01
Normal-vs-Social Drinker
5.360800E-01
Non Drinker-vs-Daily Drinker
2.886200E-01
Non Drinker-vs-Weekly Drinker
6.556400E-01
Non Drinker-vs-Occasional Drinker
7.520600E-01
Non Drinker-vs-Social Drinker
4.659000E-01
Daily Drinker-vs-Weekly Drinker
6.209800E-01
Daily Drinker-vs-Occasional Drinker
2.032200E-01
Daily Drinker-vs-Social Drinker
1.156410E-01
Weekly Drinker-vs-Occasional Drinker
4.515000E-01
Weekly Drinker-vs-Social Drinker
2.992200E-01
Occasional Drinker-vs-Social Drinker
7.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.655600E-01
Normal-vs-Grade 2
4.728300E-02
Normal-vs-Grade 3
3.783600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.955500E-04
Grade 1-vs-Grade 3
2.406400E-04
Grade 1-vs-Grade 4
2.655600E-01
Grade 2-vs-Grade 3
7.092400E-01
Grade 2-vs-Grade 4
4.728300E-02
Grade 3-vs-Grade 4
3.783600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.472800E-01
Normal-vs-NonDiabetic
3.698800E-01
Diabetic-vs-NonDiabetic
8.162600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.163020E-01
Normal-vs-NoPancreatitis
4.381600E-01
Pancreatitis-vs-NoPancreatitis
2.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.163000E-01
Normal-vs-N1
3.481000E-01
N0-vs-N1
3.799600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.055600E-01
Normal-vs-TP53-NonMutant
4.743200E-01
TP53-Mutant-vs-TP53-NonMutant
3.559800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
